Profusa (PFSA) Cash from Investing Activities (2022 - 2026)
Profusa (PFSA) posted quarterly Cash from Investing Activities of $1.1 million for Q1 2026, down 82.36% year-over-year from $6.5 million in Q1 2025, and up 213.59% quarter-over-quarter from -$1.0 million in Q4 2025.
Profusa (PFSA) Cash from Investing Activities (2022 - 2026) Analysis & Trends
Profusa's Cash from Investing Activities history runs 5 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 82.36% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at -$7.4 million (down 206.55% YoY), while the FY2025 annual figure was -$2.0 million, down 167.66% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at $1.1 million, up from -$1.0 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $185.7 million in Q1 2023, with the low at -$7.5 million in Q3 2025.
- The 5-year median for Cash from Investing Activities is $32631.5 (2024), against an average of $13.4 million.
- The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities tumbled 206421.62% in 2023, then surged 699.29% in 2024.
- Profusa's Cash from Investing Activities stood at -$37.0 in 2022, then sank by 206421.62% to -$76413.0 in 2023, then soared by 699.29% to $457936.0 in 2024, then slumped by 320.12% to -$1.0 million in 2025, then surged by 213.59% to $1.1 million in 2026.
- Business Quant data shows PFSA's Cash from Investing Activities at $1.1 million in Q1 2026, -$1.0 million in Q4 2025, and -$7.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Profusa | 92,085.85 | -282,914.15 | - | 1.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.15 Mn |
| Mar 31, 2026 | 1.15 Mn |
| Dec 31, 2025 | -1.01 Mn |
| Dec 31, 2025 | -1.01 Mn |
| Sep 30, 2025 | -7.49 Mn |
| Sep 30, 2025 | -7.49 Mn |
| Jun 30, 2025 | -1.00 |
| Jun 30, 2025 | -1.00 |
| Mar 31, 2025 | 6.49 Mn |
| Mar 31, 2025 | 6.49 Mn |
| Dec 31, 2024 | 457,936.00 |
| Dec 31, 2024 | 457,936.00 |
| Sep 30, 2024 | -112,115.00 |
| Sep 30, 2024 | -112,115.00 |
| Jun 30, 2024 | 65,264.00 |
| Jun 30, 2024 | 65,264.00 |
| Mar 31, 2024 | 2.56 Mn |
| Mar 31, 2024 | 2.56 Mn |
| Dec 31, 2023 | -76,413.00 |
| Dec 31, 2023 | -76,413.00 |